The disclosure provides for new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. Method of using such agents to treatment Short Bowel Syndrome (SBS) are also described.
本公开提供了经
脂肪酸共轭修饰的基于
表皮生长因子(
EGF)的新型试剂。还描述了使用此类试剂治疗短肠综合征(SBS)的方法。